In the following sections, chaperone-dependent pharmacodynamic mechanisms of neuroprotection corresponding to the contribution of Sigma1R and BiP to the pathogenesis of neurodegenerative diseases will be analyzed. Here, HSPA5 is linked to neurodegenerative disease.